Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?

被引:6
作者
Svicher, Valentina [1 ]
Marchetti, Giulia [2 ]
Ammassari, Adrianna [3 ]
Ceccherini-Silberstein, Francesca [1 ]
Sarmati, Loredana [4 ]
机构
[1] Univ Roma Tor Vergata, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy
[2] Univ Milan, Dept Hlth Sci, Clin Infect Dis, ASST Santi Paolo & Carlo, Milan, Italy
[3] INMI L Spallanzani, HIV AIDS Dept, Rome, Italy
[4] Univ Hosp Tor Vergata, Dept Syst Med, Clin Infect Dis, Rome, Italy
关键词
HIV-DNA; Residual viremia; Low level viremia; Genotypic resistance testin; Inflammation; Immune-activation; VIREMIA COPY-YEARS; LOW-LEVEL VIREMIA; T-CELL-ACTIVATION; PERSISTENT HIV-1 REPLICATION; SYSTEMIC IMMUNE ACTIVATION; HIV-1-INFECTED PATIENTS; DRUG-RESISTANCE; VIRAL LOAD; DARUNAVIR/RITONAVIR MONOTHERAPY; TREATMENT-NAIVE;
D O I
10.24875/AIDSRev.M17000003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The high potency and tolerability of the currently available antiretroviral drugs has modified HIV-1 infection from a life-threatening disease to a chronic illness. Nevertheless, some issues still remain open to optimize the management of HIV-1 infected patients in term of maintenance of virological suppression over time, identifying patients that could benefit from simplification therapy, and reducing co-mordibities driven by chronic inflammation. The availability of robust and affordable virological and immunological markers can help in solving these issues by providing information on the burden of HIV-1 reservoir in all the anatomical compartments in which the virus replicates as well as on persistent inflammation, immune activation and senescence despite successful virological suppression. In this light, this review is aimed at providing new insights (arising from a two-day Italian expert meeting hold in Rome in March 2016) in evaluation and monitoring of HIV-1 infection from a virological, immunological and clinical perspective. Particular attention has been focused on role of novel parameters (such as total HIV-1 DNA, residual viremia, and immunological markers) in optimizing treatment strategies, enhancing medical adherence, and individualizing monitoring.
引用
收藏
页码:119 / 133
页数:15
相关论文
共 50 条
  • [21] Enhanced Human Immunodeficiency Virus-1 Replication in CD4+ T Cells Derived From Individuals With Latent Mycobacterium tuberculosis Infection
    He, Xianbao
    Eddy, Jared J.
    Jacobson, Karen R.
    Henderson, Andrew J.
    Agosto, Luis M.
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (09) : 1550 - 1560
  • [22] Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection
    Childers, Meredith E.
    Woods, Steven Paul
    Letendre, Scott
    McCutchan, J. Allen
    Rosario, Debralee
    Grant, Igor
    Mindt, Monica Rivera
    Ellis, Ronald J.
    JOURNAL OF NEUROVIROLOGY, 2008, 14 (06) : 550 - 557
  • [23] Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection
    Meredith E. Childers
    Steven Paul Woods
    Scott Letendre
    J. Allen McCutchan
    Debralee Rosario
    Igor Grant
    Monica Rivera Mindt
    Ronald J. Ellis
    Journal of NeuroVirology, 2008, 14 : 550 - 557
  • [24] In-house human immunodeficiency virus-1 genotype resistance testing to determine highly active antiretroviral therapy resistance mutations in Hong Kong
    Chen, Jonathan H. K.
    Wong, K. H.
    Li, Patrick C. K.
    Chan, Kenny K. C.
    Lee, M. P.
    To, Sabrina W. C.
    Yam, W. C.
    HONG KONG MEDICAL JOURNAL, 2012, 18 (01) : 20 - 24
  • [25] Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1 Infected Adults in the United States
    Mukerji, Shibani S.
    Misra, Vikas
    Lorenz, David R.
    Uno, Hajime
    Morgello, Susan
    Franklin, Donald
    Ellis, Ronald J.
    Letendre, Scott
    Gabuzda, Dana
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (08) : 1182 - 1190
  • [26] Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy
    Muccini, Camilla
    Canetti, Diana
    Castagna, Antonella
    Spagnuolo, Vincenzo
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 297 - 304
  • [27] Impact of Raltegravir or Efavirenz on Cell-Associated Human Immunodeficiency Virus-1 (HIV-1) Deoxyribonucleic Acid and Systemic Inflammation in HIV-1/Tuberculosis Coinfected Adults Initiating Antiretroviral Therapy
    Delagreverie, Heloise M.
    Bauduin, Claire
    De Castro, Nathalie
    Grinsztejn, Beatriz
    Chevrier, Marc
    Jouenne, Fanelie
    Mourah, Samia
    Kalidi, Issa
    Pilotto, Jose Henrique
    Brites, Carlos
    Barcellos, Nemora Tregnago
    Amara, Ali
    Wittkop, Linda
    Molina, Jean-Michel
    Delaugerre, Constance
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (02):
  • [28] Association of CD209L tandem repeats polymorphism with susceptibility to human immunodeficiency virus-1 infection, disease progression, and treatment outcomes: a Moroccan cohort study
    Fayssel, N.
    Bensghir, R.
    Ouladlahsen, A.
    Abdelghaffar, H.
    Sodqi, M.
    Lahlou, K.
    Benjelloun, S.
    El Filali, K. Marhoum
    Ezzikouri, S.
    Wakrim, L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (05) : 513.e1 - 513.e5
  • [29] Human immunodeficiency virus infection and syphilis among homeless people in a large city of Central-Western Brazil: prevalence, risk factors, human immunodeficiency virus-1 genetic diversity, and drug resistance mutations
    Pinheiro, Raquel Silva
    Ribeiro dos Santos Carvalho, Paulie Marcelly
    de Matos, Marcos Andre
    Amorim Caetano, Karlla Antonieta
    de Paula, Andressa Cunha
    dos Santos Carneiro, Megmar Aparecida
    da Guarda Reis, Monica Nogueira
    Bringel Martins, Regina Maria
    de Araujo Stefani, Mariane Martins
    Teles, Sheila Araujo
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2021, 25 (01)
  • [30] Human Immunodeficiency Virus Viral Load Monitoring and Rate of Virologic Suppression Among Patients Receiving Antiretroviral Therapy in Democratic Republic of the Congo, 2013-2020
    Ngongo, Nadine Mayasi
    Ntambwe, Erick Kamangu
    Nani-Tuma, Hippolyte Situakibanza
    Mambimbi, Marcel Mbula
    Ndona, Madone Mandina
    Mashi, Murielle Longokolo
    Izizag, Ben Bepouka
    Lukiana, Tuna
    Ossam, Jerome Odio
    Sonzi, Donatien Mangala
    Maes, Nathalie
    Moutschen, Michel
    El Moussaoui, Majdouline
    Darcis, Gilles
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (06):